BLUEPRINT MEDICINES CORP (BPMC) Stock Analyst Ratings
NASDAQ:BPMC - Nasdaq - US09627Y1091 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 81% to BPMC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 130.03. This target is 48.33% above the current price.
BPMC was analyzed by 29 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about BPMC.
In the previous month the buy percentage consensus was at a similar level.
BPMC was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-17 | Jefferies | Initiate | Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-14 | Needham | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | Needham | Reiterate | Buy -> Buy |
| 2025-02-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-27 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-01-02 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-12-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-15 | Needham | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | JP Morgan | Initiate | Overweight |
| 2024-10-31 | Needham | Maintains | Buy -> Buy |
| 2024-10-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | Needham | Reiterate | Buy -> Buy |
| 2024-10-24 | UBS | Initiate | Neutral |
| 2024-08-05 | Needham | Maintains | Buy -> Buy |
| 2024-08-02 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-02 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-01 | Needham | Reiterate | Buy -> Buy |